Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $47.45 million. The enterprise value is $51.31 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TELO has 32.28 million shares outstanding. The number of shares has increased by 5.04% in one year.
Current Share Class | 32.28M |
Shares Outstanding | 32.28M |
Shares Change (YoY) | +5.04% |
Shares Change (QoQ) | +0.83% |
Owned by Insiders (%) | 16.49% |
Owned by Institutions (%) | 8.52% |
Float | 20.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 93.85 |
P/TBV Ratio | 108.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.19.
Current Ratio | 2.38 |
Quick Ratio | 2.17 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11,606.13 |
Financial Efficiency
Return on equity (ROE) is -1,569.59% and return on invested capital (ROIC) is -882.19%.
Return on Equity (ROE) | -1,569.59% |
Return on Assets (ROA) | -686.94% |
Return on Invested Capital (ROIC) | -882.19% |
Return on Capital Employed (ROCE) | -3,347.58% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.05% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -72.05% |
50-Day Moving Average | 1.60 |
200-Day Moving Average | 3.20 |
Relative Strength Index (RSI) | 41.04 |
Average Volume (20 Days) | 4,042,729 |
Short Selling Information
The latest short interest is 1.06 million, so 3.28% of the outstanding shares have been sold short.
Short Interest | 1.06M |
Short Previous Month | 1.59M |
Short % of Shares Out | 3.28% |
Short % of Float | 5.25% |
Short Ratio (days to cover) | 0.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.11M |
Pretax Income | n/a |
Net Income | -16.08M |
EBITDA | n/a |
EBIT | -16.11M |
Earnings Per Share (EPS) | -$0.54 |
Full Income Statement Balance Sheet
The company has $754,323 in cash and $93,432 in debt, giving a net cash position of $660,891 or $0.02 per share.
Cash & Cash Equivalents | 754,323 |
Total Debt | 93,432 |
Net Cash | 660,891 |
Net Cash Per Share | $0.02 |
Equity (Book Value) | 481,223 |
Book Value Per Share | 0.02 |
Working Capital | 481,223 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -3.17M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |